NCT02691650

Brief Summary

Goal of this study is to measure serum cholinesterase activity in patients with traumatic and/or burns injury admitted to the emergency room by using point-of- care-test system (POCT). Serum cholinesterase activity, measured using POCT system, might play an important role in the early diagnosis and prediction of patient outcome in trauma-induced systemic inflammation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
85

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2016

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

February 16, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 25, 2016

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2018

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2018

Completed
Last Updated

April 16, 2019

Status Verified

April 1, 2019

Enrollment Period

2 years

First QC Date

February 16, 2016

Last Update Submit

April 15, 2019

Conditions

Keywords

serum cholinesteraseplasma cholinesterasepseudocholinesterasesystemic inflammationSIRSpolytrauma

Outcome Measures

Primary Outcomes (1)

  • Early diagnosis of the systemic inflammation by using the serum cholinesterase activity measurement

    By using Point-of-care measurement of serum cholinesterase activity (U/l) and by observing a change in the enzyme activity over time (reduction of serum cholinesterase activity within the first 6 hours after traumatic injury) would allow an additional tool in early diagnosis and treatment of systemic inflammation.

    after completed patient recruitment, 1 year

Secondary Outcomes (1)

  • correlation of the cholinesterase activity and the trauma/disease severity scores

    after completed patient recruitment, 1 year

Study Arms (2)

polytrauma patients

Patients with severe traumatic injury, admitted to the emergency unit. Serum cholinesterase activity measurement using 10 µl whole blood, otherwise obtained through routine blood gas analysis upon arrival to the hospital.

burns patients

Patients with burns trauma, admitted to the emergency unit. Serum cholinesterase activity measurement using 10 µl whole blood, otherwise obtained through routine blood gas analysis upon arrival to the hospital.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients admitted to the emergency unit of the trauma and burns center

You may qualify if:

  • signed written consent
  • years and older
  • severe trauma (ISS \> 15)
  • burns injury (2. degree more than 15% body surface or 3 degree more than 10% body surface)
  • SIRS

You may not qualify if:

  • failure to adhere

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anaesthesia, Intensive Care Medicine and Pain Therapy, BG Trauma Center Ludwigshafen

Ludwigshafen am Rhein, Rhineland-Palatinate, 67071, Germany

Location

Biospecimen

Retention: SAMPLES WITH DNA

A miniature amount (10 μl) of whole blood is needed for the serum cholinesterase activity analysis. This blood specimen will be taken from otherwise routine blood gas analysis collection, taken upon arrival into the emergency room, as a part of the standardized ICU diagnostic and therapeutic procedure. The serum cholinesterase activity analysis, therefore, doesn't require additional blood collection.

MeSH Terms

Conditions

Wounds and InjuriesBurnsButyrylcholinesterase deficiencyMultiple Trauma

Study Officials

  • Stefan Hofer, Prof. Dr.

    Department of Anesthesiology, Heidelberg University Hospital

    PRINCIPAL INVESTIGATOR
  • Stefan Kleinschmidt, Prof. Dr.

    Department of Anaesthesia, Intensive Care Medicine and Pain Therapy, BG Trauma Centre Ludwigshafen, Ludwigshafen, Germany

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. med. Aleksandar Zivkovic

Study Record Dates

First Submitted

February 16, 2016

First Posted

February 25, 2016

Study Start

February 1, 2016

Primary Completion

February 1, 2018

Study Completion

October 1, 2018

Last Updated

April 16, 2019

Record last verified: 2019-04

Data Sharing

IPD Sharing
Will not share

Locations